Diosynth
Diosynth is a biopharmaceutical company that specializes in the development and manufacturing of active pharmaceutical ingredients (APIs) and biologics. The company has a long history of innovation and excellence in the field of biotechnology and pharmaceuticals.
History[edit | edit source]
Diosynth was originally founded as a division of Royal DSM, a global science-based company active in health, nutrition, and materials. Over the years, Diosynth has grown and evolved, becoming a leading player in the biopharmaceutical industry. In 2005, Diosynth merged with Organon International to form Schering-Plough's Organon BioSciences division. Later, in 2009, Schering-Plough was acquired by Merck & Co., and Diosynth became part of Merck's manufacturing network.
Services[edit | edit source]
Diosynth offers a wide range of services in the biopharmaceutical sector, including:
- Development and manufacturing of active pharmaceutical ingredients (APIs)
- Production of biologics, including monoclonal antibodies and recombinant proteins
- Process development and optimization
- Analytical and quality control services
- Regulatory support and compliance
Facilities[edit | edit source]
Diosynth operates several state-of-the-art manufacturing facilities around the world. These facilities are equipped with advanced technologies and adhere to the highest standards of Good Manufacturing Practice (GMP). The company's main production sites are located in:
- Groningen, Netherlands
- Research Triangle Park, North Carolina, United States
- Horsham, United Kingdom
Research and Development[edit | edit source]
Diosynth is committed to innovation and invests heavily in research and development (R&D). The company collaborates with academic institutions, research organizations, and other industry partners to advance the field of biopharmaceuticals. Diosynth's R&D efforts focus on improving manufacturing processes, developing new biologics, and enhancing the quality and efficacy of existing products.
Related Pages[edit | edit source]
- Biopharmaceutical
- Active pharmaceutical ingredient
- Biologics
- Good Manufacturing Practice
- Royal DSM
- Organon International
- Schering-Plough
- Merck & Co.
 | This hospital-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
